Tumour necrosis factor-α, but not septic plasma depresses cardiac myofilament contraction

Canadian Journal of Anaesthesia

Volumn 45, Issue 4, 1998, Pages 352-359

  Gu, Mai ^a   Bose, Ratna ^a   Bose, Deepak ^a   Yang, Juan ^a   Li, Xing ^a   Bruce Light, R ^a   Jacobs, Hans ^a   Mink, Steven N ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ESCHERICHIA COLI; HEART CONTRACTION; MUSCLE ISOMETRIC CONTRACTION; MYOCARDIAL DISEASE; MYOFILAMENT; NONHUMAN; PLASMA; PRIORITY JOURNAL; SEPSIS;

EID: 0031858519     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03012028     Document Type: Article

References (36)

1. Cunnion RE, Parrillo JE. Myocardial dysfunction in sepsis. Crit Care Clin 1989; 5: 99-118.
2. Gomez A, Wang R, Unruh H, et al. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73: 671-85.
3. Brand ED, Cowgill R, Lefer AM. Further characterization of a myocardial depressant factor present in hemorrhagic shock. J Trauma 1969; 9: 216-26.
4. Lefer AM, Rovetto MJ. Influence of a myocardial depressant factor on physiologic properties of cardiac muscle. Proc Soc Exp Biol 1986; 134: 269-73.
5. Jha P, Jacobs H, Bose D, et al. Effects of E. coli sepsis and myocardial depressant factor on interval-force relations in dogs ventricle. Am J Physiol 1993; 264: H1402-10.
6. Parker JL, Adams HR. Development of myocardial dysfunction in endotoxin shock. Am J Physiol 1985; 248:H818-26.
7. Parrillo JE, Burch C, Shelhamer JH, Parker MM, Natanson C, Schuette W. A circulating myocardial depressant substance in humans with septic shock. J Clin Invest 1985; 76: 1539-53.
8. Drapier J-C, Hibbs JB Jr. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 1988; 140: 2829-38.
9. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257: 387-9.
10. Pagani FD, Baker LS, Hsi C, Knox MA, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest 1992; 90: 389-98.
11. Pinsky MR, Vincent J-L, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 1993; 103: 565-75.
12. 2+ independent nitric oxide synthase in the myocardium. Br J Pharmacol 1992; 105: 575-80.
13. Tokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 1993; 92: 2303-12.
14. Eichenholz PW, Eichacker PQ Hoffman WD, et al. Tumor necrosis factor challenges in canines: patterns of cardiovascular dysfunction. Am J Physiol 1992; 263: H668-75.
15. Yang J, Wang R, Jacobs H, Bose D, Light RB, Mink SN. Purification of filterable cardiodepressant substance by high pressure liquid chromatography techniques in canine E. coli sepsis. Am J Respir Crit Care Med 1994; 149: A657.
16. Fabiato A, Fabiato F. Calculator program for computing the composition of the solutions containing metals and ligands used for experiments in skinned muscle cells. J Physiol Paris 1979; 75: 463-505.
17. Fabiato A. Myoplasmic tree calcium concentration reached during the twitch of an intact isolated cardiac cell and during calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned cardiac cell from the adult rat or rabbit ventricle. J Gen Physiol 1981; 78: 457-97.
18. Nosek TM, Williams MF, Zeigler ST, Godt RE. Inositol trisphosphate enhances calcium release in skinned cardiac and skeletal muscle. Am J Physiol 1986; 250 (Cell Physiol 19):C807-11.
19. Ventura-Clapier R, Mekhfi H, Vassort G. Role of creatine kinase in force development in chemically skinned rat cardiac muscle. J Gen Physiol 1987; 89: 815-37.
20. Nora R, Abrams JS, Tait NS, Hiponia DJ, Silverman HJ. Myocardial toxic effects during recombinant interleukin-2 therapy. J Natl Cancer Inst 1989; 81: 59-63.
21. Smith JA, Shah AM, Lewis MJ. Factors released from endocardium of the ferret and pig modulate myocardial contraction. J Physiol Lond 1991; 439: 1-14.
22. Zucker K, Lu P, Fuller L, Asthana D, Esquenazi V, Miller J. Cloning and expression of the cDNA for canine tumor necrosis factor-α in E. coli. Lymphokine and Cytokine Research 1994; 13: 191-6.
23. Pagani FD, Baker LS, Knox MA, Cheng H, Fink MP, Visner MS. Load-insensitive assessment of myocardial performance after tumor necrosis factor-α in dogs. Surgery 1992; 111:683-93.
24. Walley KR, Herbert PC, Wakai Y, Wilcox PG, Road JD, Cooper DJ. Decrease in left ventricular contractility after tumor necrosis factor-α infusion in dogs. J Appl Physiol 1994; 76: 1060-7.
25. Smith RA, Baglioni C, The active form of tumor necrosis factor is a trimer. J Biol Chem 1987; 260: 6951-54.
26. Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Eng J Med 1987; 316: 379-5.
27. Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 1985; 135: 3972-7.
28. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 1992; 263: H1963-6.
29. 2+ current is regulated by cyclic GMP- dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci 1991; 88: 1197-201.
30. Nawrath H. Does cyclic GMP mediate the negative inotropic effect of acetylcholine in the heart? Nature 1977; 267: 72-4.
31. Bkaily G, Sperelakis N. Injection of guanosine 5′- cyclic monophosphate into heart cells blocks calcium slow channels. Am J Physiol 1985; 248: H745-9.
32. Shah AM, Lewis MJ, Henderson AH. Effects of 8-bromo-cyclic GMP on contraction and on inotropic response of ferret cardiac muscle. J Mol Cell Cardiol 1991; 23: 55-64.
33. Dinarello CA. The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome. J Infect Dis 1991; 163: 1177-84.
34. Adamson GM, Billings RE. Tumor necrosis factor: receptor binding and expression of receptors in cultured mouse hepatocytes. J Pharmacol Exp Ther 1994; 269: 367-73.
35. Tsujimoto M, Yip YK, Vilček J. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc Natl Acad Sci 1985; 82: 7626-30.
36. Fruehauf JP, Sinha BK. Selective formation of tumor necrosis factor-α (TNFα) degradation products contributes to the TNFα mediated cytotoxicity. Oncol Res 1992; 4: 91-101.